TUSTIN, Calif., Feb. 2 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a vertically integrated pharmaceutical company with operations in the US and China, announced today its Chairman and CEO Mr. Douglas MacLellan will appear on Fox Business News at 6:40 a.m. ET (3:40 a.m. PT) today, February 2, 2009.
Mr. MacLellan was invited as a guest expert on Fox Business News to discuss the current business environment for China-based pharmaceutical and healthcare companies and how AMDL is leading the industry as one of the first US-based companies to enforce and implement Westernized business practices, including SOX-compliant operating procedures and GAPP-certified accounting practices, across its US and China operations. Mr. MacLellan also offers opinion on China's healthcare reform plan and the $124 billion capital investment the country plans to make in its medical and health-care system.
According to Mr. MacLellan, "I'm extremely honored join Fox Business News to offer insight on these important topics. They are subjects investors inquire about most often when we communicate the AMDL story, and topics that impact Wall Street's overall view and investing appetite for China-based pharmaceutical companies."
Despite the challenging economic environment, AMDL has successfully managed its US and China-based operations, delivering strong and consistent YOY growth of 100% or more over the past four years. AMDL expects to continue this forward momentum in FY 2009. (http://www.amdl.com)
FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. FBN is headquartered in New York, the business capital of the world. Launched in October 2007, the Network is available in more than 35 million homes in major markets across the United States. Owned by News Corp., the Network has bureaus in Chicago, Los Angeles, Silicon Valley, Washington, DC and London. (http://www.foxbusiness.com).
About AMDL:
Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China. (http://www.amdl.com)
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
AMDL Contact:
Kristine Szarkowitz
Director-Investor Relations
kszarkowitz@amdl.com
(Tel :) 206. 310.5323
